These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36221816)

  • 21. Cancer!? I Don't Have Time for That: Impact of a Psychosocial Intervention for Young Adults with Cancer.
    Aubin S; Rosberger Z; Hafez N; Noory MR; Perez S; Lehmann S; Batist G; Kavan P
    J Adolesc Young Adult Oncol; 2019 Apr; 8(2):172-189. PubMed ID: 30484730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence of brain-derived neurotrophic factor in ameliorating cancer-related cognitive impairment: A systematic review of human studies.
    Ng DQ; Chan D; Agrawal P; Zhao W; Xu X; Acharya M; Chan A
    Crit Rev Oncol Hematol; 2022 Aug; 176():103748. PubMed ID: 35718064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.
    Tan CJ; Lim SWT; Toh YL; Ng T; Yeo A; Shwe M; Foo KM; Chu P; Jain A; Koo SL; Dent RA; Ng RCH; Yap YS; Lim EH; Loh KW; Chay WY; Lee GE; Tan TJY; Beh SY; Wong M; Chan JJ; Khor CC; Ho HK; Chan A
    Mol Neurobiol; 2019 Jul; 56(7):4741-4750. PubMed ID: 30382534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study.
    Karthikeyan S; Dimick MK; Fiksenbaum L; Jeong H; Birmaher B; Kennedy JL; Lanctôt K; Levitt AJ; Miller GE; Schaffer A; Young LT; Youngstrom EA; Andreazza AC; Goldstein BI
    Brain Behav Immun; 2022 Feb; 100():278-286. PubMed ID: 34896179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study.
    Cheung YT; Ng T; Shwe M; Ho HK; Foo KM; Cham MT; Lee JA; Fan G; Tan YP; Yong WS; Madhukumar P; Loo SK; Ang SF; Wong M; Chay WY; Ooi WS; Dent RA; Yap YS; Ng R; Chan A
    Ann Oncol; 2015 Jul; 26(7):1446-51. PubMed ID: 25922060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive Impairment in Survivors of Adolescent and Early Young Adult Onset Non-CNS Cancers: Does Chemotherapy Play a Role?
    John TD; Sender LS; Bota DA
    J Adolesc Young Adult Oncol; 2016 Sep; 5(3):226-31. PubMed ID: 27078009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subjective cognitive impairment and brain structural networks in Chinese gynaecological cancer survivors compared with age-matched controls: a cross-sectional study.
    Zeng Y; Cheng ASK; Song T; Sheng X; Zhang Y; Liu X; Chan CCH
    BMC Cancer; 2017 Nov; 17(1):796. PubMed ID: 29179739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal exploration of cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma: protocol for a feasibility study.
    Gates P; Gough K; Dhillon H; Wilson C; Hawkes E; Dore V; Perchyonok Y; Rowe CC; Walker AK; Vardy JL; de Ruiter M; Krishnasamy M
    BMJ Open; 2020 Sep; 10(9):e038312. PubMed ID: 32994248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loneliness as a risk factor for cancer-related cognitive impairment: a secondary data analysis from the Haze study.
    Sleight AG; Myers JS; Cook-Wiens G; Baynes R; Jo MY; Asher A
    Disabil Rehabil; 2023 Jul; 45(14):2325-2328. PubMed ID: 35760769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Evaluation of the Multifactorial Model of Cancer-Related Cognitive Impairment.
    Oppegaard KR; Mayo SJ; Armstrong TS; Kober KM; Anguera JA; Wright F; Levine JD; Conley YP; Paul S; Cooper B; Miaskowski C
    Nurs Res; 2023 Jul-Aug 01; 72(4):272-280. PubMed ID: 37104681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer.
    Vardy JL; Stouten-Kemperman MM; Pond G; Booth CM; Rourke SB; Dhillon HM; Dodd A; Crawley A; Tannock IF
    Brain Imaging Behav; 2019 Feb; 13(1):15-26. PubMed ID: 28466438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Clinician's Toolbox: Assessing the Sexual Impacts of Cancer on Adolescents and Young Adults with Cancer (AYAC).
    Aubin S; Perez S
    Sex Med; 2015 Sep; 3(3):198-212. PubMed ID: 26468383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-related cognitive impairment (CRCI), depression and quality of life in gynecological cancer patients: a prospective study.
    De Rosa N; Della Corte L; Giannattasio A; Giampaolino P; Di Carlo C; Bifulco G
    Arch Gynecol Obstet; 2021 Jun; 303(6):1581-1588. PubMed ID: 33404703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy-related cognitive impairment in older patients with cancer.
    Loh KP; Janelsins MC; Mohile SG; Holmes HM; Hsu T; Inouye SK; Karuturi MS; Kimmick GG; Lichtman SM; Magnuson A; Whitehead MI; Wong ML; Ahles TA
    J Geriatr Oncol; 2016 Jul; 7(4):270-80. PubMed ID: 27197918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protocol for a prospective, longitudinal study of cognitive impairment in young patients with cancer: a multidisciplinary neuroscience approach (MyBrain).
    Nordhjem BJT; Tjørnlund M; Thomsen BL; Hjerming M; Kjær TW; Pappot H; Hjalgrim LL
    BMJ Open; 2023 May; 13(5):e070534. PubMed ID: 37202143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unmet Needs, Barriers, and Facilitators for Conducting Adolescent and Young Adult Cancer Survivorship Research in Southern California: A Delphi Survey.
    Chan A; Ports K; Ng DQ; Nasr R; Hsu S; Armenian S; Baca N; Freyer DR; Kuo DJ; Lin C; Milam J; Valerin J; Yun C; Torno L
    J Adolesc Young Adult Oncol; 2023 Oct; 12(5):765-772. PubMed ID: 36695742
    [No Abstract]   [Full Text] [Related]  

  • 37. Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study.
    Diniz BS; Reynolds CF; Begley A; Dew MA; Anderson SJ; Lotrich F; Erickson KI; Lopez O; Aizenstein H; Sibille EL; Butters MA
    J Psychiatr Res; 2014 Feb; 49():96-101. PubMed ID: 24290367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.
    Chae JW; Chua PS; Ng T; Yeo AHL; Shwe M; Gan YX; Dorajoo S; Foo KM; Loh KW; Koo SL; Chay WY; Tan TJY; Beh SY; Lim EH; Lee GE; Dent R; Yap YS; Ng R; Ho HK; Chan A
    Breast Cancer Res Treat; 2018 Apr; 168(3):713-721. PubMed ID: 29313215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of cognitive impairment and breast cancer survivorship on quality of life in younger breast cancer survivors.
    Von Ah D; Crouch AD; Monahan PO; Stump TE; Unverzagt FW; Storey S; Cohee AA; Cella D; Champion VL
    J Cancer Surviv; 2022 Aug; 16(4):812-822. PubMed ID: 34173970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder.
    Requena-Ocaña N; Araos P; Serrano-Castro PJ; Flores-López M; García-Marchena N; Oliver-Martos B; Ruiz JJ; Gavito A; Pavón FJ; Serrano A; Mayoral F; Suarez J; Fonseca FR
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.